Latest Partnerships News

Far East Gold Ltd has advanced its exploration efforts in Indonesia with imminent drilling at Idenburg and Trenggalek, backed by a $4.78 million strategic investment from Xingye Gold, increasing their stake to nearly 20%.

Strategic Energy Resources advances its copper-gold and polymetallic exploration with refined drill targets at Isa North, promising anomalies at South Cobar, and a major new gold project granted in Queensland, while managing funding and asset divestment.

Nuchev Limited reported a remarkable 215% increase in quarterly revenue, driven by the strategic launch of Oli6® in Vietnam and the acquisition of bWellness, signaling robust expansion across key Asia-Pacific markets.

Odyssey Gold has initiated a Technical Study to explore mining and processing strategies for its Tuckanarra Project, leveraging a new partnership with Monument Murchison Ltd to potentially process ore at the nearby Burnakura Mill.

AKORA Resources has confirmed a robust Pre-Feasibility Study for its Bekisopa iron ore project in Madagascar, highlighting strong financial metrics and government support that pave the way for a 2Mtpa direct shipping ore operation.

AusQuest Limited has unveiled significant maiden drilling results at its Cangallo Project in southern Peru, confirming a large-scale porphyry copper-gold system. The company secured $7.5 million in funding to fast-track exploration activities across Peru and Australia.

Lumos Diagnostics reported a 21% quarter-on-quarter revenue increase in Q3 FY25, driven by strong product sales and expanded development agreements. The company also secured Medicare coverage in key US regions and advanced its pivotal FebriDx CLIA waiver study with FDA submission expected by year-end.

RMA Global Limited reported a robust Q3 FY25, achieving a 21% revenue increase to $5.5 million and marking its third consecutive quarter of positive operating cash flow, driven by US market expansion and the strategic acquisition of Curated Social.

BrainChip Holdings advanced its neuromorphic AI technology through significant contracts with the Swedish National Space Agency and the U.S. Air Force, while exploring a potential redomiciling to the US. The company reported steady cash outflows and ongoing strategic partnerships.

Aroa Biosurgery reports a second consecutive quarter of positive operating cash flow and record sales for its Myriad product line, while maintaining full-year FY25 revenue and EBITDA guidance.

Algorae Pharmaceuticals reports significant progress in its AI-driven drug discovery platform, unveiling 24 novel oncology targets and appointing a seasoned Chief Commercial Officer to bolster market readiness.

Decidr AI Industries signals a strategic pivot to AI with a successful $11 million capital raise, new multi-year contracts, and expanded global partnerships, driving early commercial traction and robust e-commerce growth.